DIADEMA PARTNERS LP: 13F holdings
CIK 20261722026Q2
| Positions | 116 |
|---|
| Reported value | $828.3m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 116 (+5 vs prior quarter) |
|---|
| Reported value | $828.3m (+45.4%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| AMGN AMGEN INC | 102,701 | $37.2m | 4.5% |
| UTHR UNITED THERAPEUTICS CORP DEL | 52,989 | $28.7m | 3.5% |
| RVMD REVOLUTION MEDICINES INC | 139,218 | $26.1m | 3.1% |
| ABVX ABIVAX SA | 163,644 | $21.6m | 2.6% |
| COGT COGENT BIOSCIENCES INC | 493,664 | $19.1m | 2.3% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 312,846 | $17.9m | 2.2% |
| VKTX VIKING THERAPEUTICS INC | 441,808 | $17.2m | 2.1% |
| EWTX EDGEWISE THERAPEUTICS INC | 272,214 | $11.1m | 1.3% |
| KOD KODIAK SCIENCES INC | 218,117 | $8.5m | 1.0% |
| IMCR IMMUNOCORE HLDGS PLC | 254,863 | $8.1m | 1.0% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2026172")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples